 This hypothesis is supported by the fact that the loss of neuromelanin observed in Parkinson's disease is accompanied by an increase in iron levels in the brain.Evidence exists in support of a highly cross-linked heteropolymer bound covalently to matrix scaffolding melanoproteins.It has been proposed that the ability of melanin to act as an antioxidant is directly proportional to its degree of polymerization or molecular weight.